MA25590A1 - Agent actif de delivraison de poudre seche - Google Patents

Agent actif de delivraison de poudre seche

Info

Publication number
MA25590A1
MA25590A1 MA25762A MA25762A MA25590A1 MA 25590 A1 MA25590 A1 MA 25590A1 MA 25762 A MA25762 A MA 25762A MA 25762 A MA25762 A MA 25762A MA 25590 A1 MA25590 A1 MA 25590A1
Authority
MA
Morocco
Prior art keywords
active agent
dry powder
powder delivery
delivery
dry
Prior art date
Application number
MA25762A
Other languages
English (en)
Inventor
Clark Andrew
Chang Kuo Mei
John Aldous Barry
Lalor Cecily
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of MA25590A1 publication Critical patent/MA25590A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MA25762A 1998-09-14 1999-09-09 Agent actif de delivraison de poudre seche MA25590A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
MA25590A1 true MA25590A1 (fr) 2002-12-31

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25762A MA25590A1 (fr) 1998-09-14 1999-09-09 Agent actif de delivraison de poudre seche

Country Status (44)

Country Link
EP (1) EP1117442A1 (fr)
JP (1) JP2002524535A (fr)
KR (1) KR20010075063A (fr)
CN (1) CN1317977A (fr)
AP (1) AP1374A (fr)
AR (1) AR022090A1 (fr)
AU (1) AU753014B2 (fr)
BG (1) BG105430A (fr)
BR (1) BR9913722A (fr)
CA (1) CA2343920A1 (fr)
CO (1) CO5130023A1 (fr)
CZ (1) CZ2001829A3 (fr)
DZ (1) DZ2892A1 (fr)
EA (1) EA003476B1 (fr)
EE (1) EE200100151A (fr)
GE (1) GEP20043257B (fr)
GT (1) GT199900156A (fr)
HK (1) HK1042231A1 (fr)
HN (1) HN1999000159A (fr)
HR (1) HRP20010189A2 (fr)
HU (1) HUP0103837A3 (fr)
ID (1) ID28845A (fr)
IL (2) IL141562A0 (fr)
IS (1) IS5878A (fr)
LT (1) LT4897B (fr)
LV (1) LV12658B (fr)
MA (1) MA25590A1 (fr)
MY (1) MY129282A (fr)
NO (1) NO20011251L (fr)
NZ (1) NZ510168A (fr)
OA (1) OA11781A (fr)
PA (1) PA8481901A1 (fr)
PE (1) PE20001061A1 (fr)
PL (1) PL195574B1 (fr)
SA (1) SA99200718B1 (fr)
SK (1) SK3442001A3 (fr)
TN (1) TNSN99173A1 (fr)
TR (1) TR200101182T2 (fr)
TW (1) TWI226248B (fr)
UA (1) UA76085C2 (fr)
UY (1) UY25711A1 (fr)
WO (1) WO2000015262A1 (fr)
YU (1) YU24201A (fr)
ZA (1) ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
HK1049621A1 (zh) 1999-06-09 2003-05-23 罗伯特‧E‧希弗斯 超临界流体辅助的喷雾和鼓泡乾燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (fr) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Administration d'esters medicamenteux par inhalation
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (fr) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2003072734A2 (fr) 2002-02-25 2003-09-04 Diffusion Pharmaceuticals Llc Sels carotenoides trans bipolaires et leurs utilisations
CA2491129A1 (fr) * 2002-07-03 2004-01-15 Brigham And Women's Hospital, Inc. Introduction par les voies aeriennes centrales pour l'administration systemique d'agents therapeutiques
JP2006513238A (ja) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
UA95903C2 (ru) * 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноиды, их синтез, лекарственная форма и применение
KR20070110418A (ko) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 입자 및 그 입자를 함유하는 제제
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
CN101541311B (zh) * 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
EP1925295A1 (fr) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Formule de poudre stable contenant un nouveau anticholinergique
EP3483140A1 (fr) 2007-04-13 2019-05-15 Diffusion Pharmaceuticals LLC Utilisation de transcaroténoïdes bipolaires en tant que prétraitement et dans le traitement d'une maladie vasculaire périphérique
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EA201070544A1 (ru) 2007-10-31 2010-12-30 Диффьюжн Фармасьютикалз Ллс Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
ES2661215T3 (es) * 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
KR101875843B1 (ko) 2009-06-22 2018-07-06 디퓨젼 파마슈티컬즈 엘엘씨 확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도
CN105287473A (zh) 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
WO2017165667A1 (fr) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Utilisation de caroténoïdes trans bipolaires avec une chimiothérapie et une radiothérapie en vue du traitement d'un cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
EP4493276A4 (fr) * 2022-03-18 2025-03-05 Pulmocures Ilac Egitim Danismanlik A.S. Formes posologiques de substances actives utilisées contre des maladies virales dans un dispositif inhalateur de poudre sèche pour des symptômes provoqués par la covid-19 et d'autres maladies pulmonaires virales

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
EP0611567B1 (fr) * 1992-06-12 2002-08-28 Teijin Limited Poudre ultra-fine pour inhalation et production de cette poudre
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (de) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
JP2002524535A (ja) 2002-08-06
WO2000015262A1 (fr) 2000-03-23
YU24201A (sh) 2003-08-29
PE20001061A1 (es) 2000-10-08
MY129282A (en) 2007-03-30
IL141562A (en) 2007-07-24
CA2343920A1 (fr) 2000-03-23
CN1317977A (zh) 2001-10-17
ID28845A (id) 2001-07-05
HRP20010189A2 (en) 2005-04-30
CZ2001829A3 (cs) 2001-09-12
CO5130023A1 (es) 2002-02-27
PL195574B1 (pl) 2007-10-31
LT4897B (lt) 2002-02-25
PA8481901A1 (es) 2002-04-25
LT2001021A (en) 2001-11-26
OA11781A (en) 2005-07-26
BG105430A (en) 2001-12-29
HUP0103837A2 (hu) 2002-05-29
AP1374A (en) 2005-02-28
HK1042231A1 (zh) 2002-08-09
NZ510168A (en) 2003-09-26
ZA200101995B (en) 2002-03-11
AU753014B2 (en) 2002-10-03
TNSN99173A1 (fr) 2005-11-10
EE200100151A (et) 2002-06-17
LV12658B (lv) 2001-09-20
LV12658A (lv) 2001-05-20
EP1117442A1 (fr) 2001-07-25
UA76085C2 (en) 2006-07-17
GT199900156A (es) 2001-03-07
SA99200718B1 (ar) 2006-11-04
PL346768A1 (en) 2002-02-25
GEP20043257B (en) 2004-06-25
AP2001002093A0 (en) 2001-03-31
TWI226248B (en) 2005-01-11
DZ2892A1 (fr) 2003-12-15
UY25711A1 (es) 1999-11-17
NO20011251L (no) 2001-04-17
AR022090A1 (es) 2002-09-04
TR200101182T2 (tr) 2001-09-21
HUP0103837A3 (en) 2002-11-28
IL141562A0 (en) 2002-03-10
NO20011251D0 (no) 2001-03-13
IS5878A (is) 2001-03-05
EA003476B1 (ru) 2003-06-26
HN1999000159A (es) 1999-11-11
BR9913722A (pt) 2001-05-29
KR20010075063A (ko) 2001-08-09
EA200100300A1 (ru) 2001-10-22
AU6039799A (en) 2000-04-03
SK3442001A3 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
MA26033A1 (fr) Agent active de livraison aerosol
LV12658A (lv) Dry powder active agent pulmonary delivery
IL149554A0 (en) Fungicidal combinations of active substances
IS2004B (is) Lyfjasamsetningar sem innihalda vorikónasól
DE60039829D1 (de) Pulversprühpistole
IS6263A (is) Lyfjasamsetningar, sem innihalda trípeptíð
DE69826704D1 (de) Pleuromutlin-derivate als antimikrobielles wirkungsmittel
GB0216125D0 (en) Fibers providing controlled active agent delivery
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
EP1487417A4 (fr) Formulations de medicament en poudre seche
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
NO20015670L (no) Forbedrede farmasöytiske formuleringer
PT1227724E (pt) Agente herbicida
HUP0105229A3 (en) Fungicidal active substance combinations
DE59902159D1 (de) Aktiver mikromischer
PL355623A1 (en) Fungicidally active substance combinations
NO20005880D0 (no) Bioreduktive cytotoksiske midler
FR2797156B1 (fr) Distributeur de poudre
DE69905278D1 (de) Insectizide mittel
DE60019505D1 (de) Mikrobizide Wirksubstanzen
ES1048018Y (es) Paquete de cigarrillos.
ZA200202759B (en) Synergistic herbicidal active substance combinations.
HUP0201986A2 (en) Fungicidal combinations of active substances
FR2796699B1 (fr) Distributeur rotatif de poudre
GB2351221B (en) Animal cage